Big Move For Can-Fite BioPharma Ltd.
Tue, Mar 16, 2021 at 05:30 PM
Can-Fite BioPharma Ltd. (CANF:NYSEMKT) shot up at $2.92, representing a gain of 43.1%. On Mon 15 Mar 21, CANF:NYSEMKT hit a New 2-Week High of $2.04. The stock appeared on our News Catalysts scanner on Tue 16 Mar 21 at 01:20 PM in the 'AGREEMENT' category. From Mon 01 Mar 21, the stock recorded 40.00% Up Days and 18.18% Green Days
The stock spiked on Mon 22 Feb 21 at $2.98 with a volume of 13M+, and its share price has been moving sideways in recent weeks.
About Can-Fite BioPharma Ltd. (CANF:NYSEMKT)
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.
Top 10 Gainers:
- SunLink Health Systems, Inc. (SSY:NYSEMKT), 151.3%
- FTCV (FTCV:NASDAQ), 43.43%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 43.14%
- Enzo Biochem, Inc. (ENZ:NYSE), 37.84%
- Lizhi Inc. (LIZI:NASDAQ), 29.51%
- New Fortress Energy LLC (NFE:NASDAQ), 27.38%
- aTyr Pharma, Inc. (LIFE:NASDAQ), 26.34%
- Capital Senior Living Corporation (CSU:NYSE), 24.81%
- CYTH (CYTH:NASDAQ), 21.91%
- J.Jill, Inc. (JILL:NYSE), 21.43%